Phlexglobal, providers of Trial Master File (TMF) technology and services solutions, and LUZ, a language translation company for life sciences, have entered into a partnership to offer a full eTMF and document translation solution.
By introducing a working relationship and marketing alliance, the two organizations will be able to co-present business opportunities and co-market their capabilities.
“We are very pleased to have partnered with a leading TMF solution provider such as Phlexglobal,” comments Monique Rivas, co-founder and CEO LUZ. “This strategic alliance enables both companies to deploy their core competencies in a seamless fashion through a complimentary solution portfolio. More importantly, life science companies that seek greater integration of TMF services and technologies and clinical document translation services and technologies will find this partnership a logical step for enabling more transparent and effective support during clinical trials.”
“Life sciences companies require translations of key essential clinical documents that become part of their TMF. These translations must meet quality standards and be completed in a timely manner,” comments Rick Riegel, CEO Phlexglobal. ”Our partnership with LUZ allows us to incorporate translations into our business process to ensure inclusion in the TMF and brings a clinical translation solution to our clients.”